Pseudocowpox virus, a novel vector to enhance the therapeutic efficacy of antitumor vaccination.
Saved in:
| Title: | Pseudocowpox virus, a novel vector to enhance the therapeutic efficacy of antitumor vaccination. |
|---|---|
| Authors: | Ramos RN; Institut Curie INSERM U932, and Centre d'Investigation Clinique Biotherapie CICBT 1428 PSL Research University Paris France.; Present address: Laboratório de Investigação Médica em Patogênese e Terapia dirigida em Onco-Imuno-Hematologia Hospital das Clínicas Faculdade de Medicina da Universidade de São Paulo (HCFMUSP) São Paulo Brazil.; Present address: Instituto D'Or de Ensino e Pesquisa São Paulo Brazil., Tosch C; Transgene SA Illkirch-Graffenstaden France., Kotsias F; Institut Curie INSERM U932, and Centre d'Investigation Clinique Biotherapie CICBT 1428 PSL Research University Paris France., Claudepierre MC; Transgene SA Illkirch-Graffenstaden France., Schmitt D; Transgene SA Illkirch-Graffenstaden France., Remy-Ziller C; Transgene SA Illkirch-Graffenstaden France., Hoffmann C; Transgene SA Illkirch-Graffenstaden France., Ricordel M; Transgene SA Illkirch-Graffenstaden France., Nourtier V; Transgene SA Illkirch-Graffenstaden France., Farine I; Transgene SA Illkirch-Graffenstaden France., Laruelle L; Transgene SA Illkirch-Graffenstaden France., Hortelano J; Transgene SA Illkirch-Graffenstaden France., Spring-Giusti C; Transgene SA Illkirch-Graffenstaden France., Sedlik C; Institut Curie INSERM U932, and Centre d'Investigation Clinique Biotherapie CICBT 1428 PSL Research University Paris France., Le Tourneau C; Department of Drug Development and Innovation (D3i) Institut Curie Paris and Saint-Cloud France., Hoffmann C; Institut Curie INSERM U932, and Centre d'Investigation Clinique Biotherapie CICBT 1428 PSL Research University Paris France.; Department of Surgical Oncology Institut Curie PSL Research University Paris France., Silvestre N; Transgene SA Illkirch-Graffenstaden France., Erbs P; Transgene SA Illkirch-Graffenstaden France., Bendjama K; Transgene SA Illkirch-Graffenstaden France., Thioudellet C; Transgene SA Illkirch-Graffenstaden France., Quemeneur E; Transgene SA Illkirch-Graffenstaden France., Piaggio E; Institut Curie INSERM U932, and Centre d'Investigation Clinique Biotherapie CICBT 1428 PSL Research University Paris France., Rittner K; Transgene SA Illkirch-Graffenstaden France. |
| Source: | Clinical & translational immunology [Clin Transl Immunology] 2022 May 08; Vol. 11 (5), pp. e1392. Date of Electronic Publication: 2022 May 08 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons Australia, Ltd. on behalf of Australasian Society for Immunology Inc Country of Publication: Australia NLM ID: 101638268 Publication Model: eCollection Cited Medium: Print ISSN: 2050-0068 (Print) Linking ISSN: 20500068 NLM ISO Abbreviation: Clin Transl Immunology Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35573979 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Pseudocowpox virus, a novel vector to enhance the therapeutic efficacy of antitumor vaccination. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ramos+RN%22">Ramos RN</searchLink>; Institut Curie INSERM U932, and Centre d'Investigation Clinique Biotherapie CICBT 1428 PSL Research University Paris France.; Present address: Laboratório de Investigação Médica em Patogênese e Terapia dirigida em Onco-Imuno-Hematologia Hospital das Clínicas Faculdade de Medicina da Universidade de São Paulo (HCFMUSP) São Paulo Brazil.; Present address: Instituto D'Or de Ensino e Pesquisa São Paulo Brazil.<br /><searchLink fieldCode="AU" term="%22Tosch+C%22">Tosch C</searchLink>; Transgene SA Illkirch-Graffenstaden France.<br /><searchLink fieldCode="AU" term="%22Kotsias+F%22">Kotsias F</searchLink>; Institut Curie INSERM U932, and Centre d'Investigation Clinique Biotherapie CICBT 1428 PSL Research University Paris France.<br /><searchLink fieldCode="AU" term="%22Claudepierre+MC%22">Claudepierre MC</searchLink>; Transgene SA Illkirch-Graffenstaden France.<br /><searchLink fieldCode="AU" term="%22Schmitt+D%22">Schmitt D</searchLink>; Transgene SA Illkirch-Graffenstaden France.<br /><searchLink fieldCode="AU" term="%22Remy-Ziller+C%22">Remy-Ziller C</searchLink>; Transgene SA Illkirch-Graffenstaden France.<br /><searchLink fieldCode="AU" term="%22Hoffmann+C%22">Hoffmann C</searchLink>; Transgene SA Illkirch-Graffenstaden France.<br /><searchLink fieldCode="AU" term="%22Ricordel+M%22">Ricordel M</searchLink>; Transgene SA Illkirch-Graffenstaden France.<br /><searchLink fieldCode="AU" term="%22Nourtier+V%22">Nourtier V</searchLink>; Transgene SA Illkirch-Graffenstaden France.<br /><searchLink fieldCode="AU" term="%22Farine+I%22">Farine I</searchLink>; Transgene SA Illkirch-Graffenstaden France.<br /><searchLink fieldCode="AU" term="%22Laruelle+L%22">Laruelle L</searchLink>; Transgene SA Illkirch-Graffenstaden France.<br /><searchLink fieldCode="AU" term="%22Hortelano+J%22">Hortelano J</searchLink>; Transgene SA Illkirch-Graffenstaden France.<br /><searchLink fieldCode="AU" term="%22Spring-Giusti+C%22">Spring-Giusti C</searchLink>; Transgene SA Illkirch-Graffenstaden France.<br /><searchLink fieldCode="AU" term="%22Sedlik+C%22">Sedlik C</searchLink>; Institut Curie INSERM U932, and Centre d'Investigation Clinique Biotherapie CICBT 1428 PSL Research University Paris France.<br /><searchLink fieldCode="AU" term="%22Le+Tourneau+C%22">Le Tourneau C</searchLink>; Department of Drug Development and Innovation (D3i) Institut Curie Paris and Saint-Cloud France.<br /><searchLink fieldCode="AU" term="%22Hoffmann+C%22">Hoffmann C</searchLink>; Institut Curie INSERM U932, and Centre d'Investigation Clinique Biotherapie CICBT 1428 PSL Research University Paris France.; Department of Surgical Oncology Institut Curie PSL Research University Paris France.<br /><searchLink fieldCode="AU" term="%22Silvestre+N%22">Silvestre N</searchLink>; Transgene SA Illkirch-Graffenstaden France.<br /><searchLink fieldCode="AU" term="%22Erbs+P%22">Erbs P</searchLink>; Transgene SA Illkirch-Graffenstaden France.<br /><searchLink fieldCode="AU" term="%22Bendjama+K%22">Bendjama K</searchLink>; Transgene SA Illkirch-Graffenstaden France.<br /><searchLink fieldCode="AU" term="%22Thioudellet+C%22">Thioudellet C</searchLink>; Transgene SA Illkirch-Graffenstaden France.<br /><searchLink fieldCode="AU" term="%22Quemeneur+E%22">Quemeneur E</searchLink>; Transgene SA Illkirch-Graffenstaden France.<br /><searchLink fieldCode="AU" term="%22Piaggio+E%22">Piaggio E</searchLink>; Institut Curie INSERM U932, and Centre d'Investigation Clinique Biotherapie CICBT 1428 PSL Research University Paris France.<br /><searchLink fieldCode="AU" term="%22Rittner+K%22">Rittner K</searchLink>; Transgene SA Illkirch-Graffenstaden France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101638268%22">Clinical & translational immunology</searchLink> [Clin Transl Immunology] 2022 May 08; Vol. 11 (5), pp. e1392. <i>Date of Electronic Publication: </i>2022 May 08 (<i>Print Publication: </i>2022). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons+Australia%2C+Ltd%2E+on+behalf+of+Australasian+Society+for+Immunology+Inc%22">John Wiley & Sons Australia, Ltd. on behalf of Australasian Society for Immunology Inc </searchLink><i>Country of Publication: </i>Australia <i>NLM ID: </i>101638268 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2050-0068 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220500068%22">20500068 </searchLink><i>NLM ISO Abbreviation: </i>Clin Transl Immunology <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35573979 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cti2.1392 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e1392 Titles: – TitleFull: Pseudocowpox virus, a novel vector to enhance the therapeutic efficacy of antitumor vaccination. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ramos RN – PersonEntity: Name: NameFull: Tosch C – PersonEntity: Name: NameFull: Kotsias F – PersonEntity: Name: NameFull: Claudepierre MC – PersonEntity: Name: NameFull: Schmitt D – PersonEntity: Name: NameFull: Remy-Ziller C – PersonEntity: Name: NameFull: Hoffmann C – PersonEntity: Name: NameFull: Ricordel M – PersonEntity: Name: NameFull: Nourtier V – PersonEntity: Name: NameFull: Farine I – PersonEntity: Name: NameFull: Laruelle L – PersonEntity: Name: NameFull: Hortelano J – PersonEntity: Name: NameFull: Spring-Giusti C – PersonEntity: Name: NameFull: Sedlik C – PersonEntity: Name: NameFull: Le Tourneau C – PersonEntity: Name: NameFull: Hoffmann C – PersonEntity: Name: NameFull: Silvestre N – PersonEntity: Name: NameFull: Erbs P – PersonEntity: Name: NameFull: Bendjama K – PersonEntity: Name: NameFull: Thioudellet C – PersonEntity: Name: NameFull: Quemeneur E – PersonEntity: Name: NameFull: Piaggio E – PersonEntity: Name: NameFull: Rittner K IsPartOfRelationships: – BibEntity: Dates: – D: 08 M: 05 Text: 2022 May 08 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 2050-0068 Numbering: – Type: volume Value: 11 – Type: issue Value: 5 Titles: – TitleFull: Clinical & translational immunology Type: main |
| ResultId | 1 |